The role of monocytes and macrophages in delayed xenograft rejection

Xenotransplantation

Volumn 4, Issue 1, 1997, Pages 40-48

  Fryer, Jonathan P ^a,b   Chen, Sally ^a   Johnson, Eric ^a   Simone, Pamela ^a   Sun, Lin Hong ^a   Goswitz, Joseph J ^a   Matas, Arthur J ^a  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Macrophages; Monocytes; Rejection; Xenograft

Indexed keywords

EID: 0002039949     PISSN: 0908665X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1399-3089.1997.tb00163.x     Document Type: Article

References (33)

1. LEVENTHAL JR, DALMASSO AP, CROMWELL JW, et al. Prolongation of cardiac xenograft survival by depletion of complement. Transplantation 1993:55:857-866.
2. HANCOCK WW, BLAKELY ML, VAN DER WERF WJ, et al. Rejection of guinea pig cardiac xenografts post-cobra venom factor therapy is associated with infiltration by mononuclear cells secreting interferon-gamma and diffuse endothelial activation. Transpl Proc 1993:25:2932.
3. LEVENTHAL JR, SAKIYALAK P, WITSON J, et al. The synergistic effect of combined antibody and complement depletion on discordant cardiac xenograft survival in non-human primates. Transplantation 1994:57:974.
4. SACHS DH. The pig as a potential xenograft donor. Vet Immunol Immunopathol 1994:43:185-191.
5. MAGEE JC, COLLINS BH, HARLAND RC, et al. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin. Transpl Proc 1995:27:271.
6. YANNOUTSOS N, LANGFORD GA, Cozzi E, et al. Production of pigs transgenic for human regulators of complement activation. Transpl Proc 1995:27:324.
7. MCCURRY KR, KOOYMAN D, DIAMOND L, et al. Human complement regulatory proteins in transgenic animals regulate complement activation in xenoperfused organs. Transpl Proc 1995:27:317.
8. HANCOCK WW, BACH FB. The immunopathology of discordant xenograft rejection. Xenotransplantation 1994:2:68.
9. LEVENTHAL JR, MATAS AJ, SUN LH, et al. The immunopathology of cardiac xenograft rejection in the guinea pigto-rat model. Transplantation 1993:56:1-10.
10. FRYER JP, LEVENTHAL JR, DALMASSO AP, et al. Cellular rejection in discordant xenografts when hyperacute rejection is prevented: Analysis using adoptive and passive transfer. Transplant Immunology 1994:2:87-93.
11. PRUITT SK, KIRK AD, BOLLINGER RR, et al. The effect of soluble complement receptor type 1 on hyperacute rejection of porcine xenografts. Transplantation 1994:57:363-370.
12. BLAKELY ML, VAN DER WERF WJ, DALMASSO AP, BACH FH. Anti-B cell agents: Suppression of natural antibodies and prolongation of survival in discordant xenografts. Transpl Proc 1994:26:1374-1375.
13. FRYER JP, LEVENTHAL JR, DALMASSO AP, et al. Beyond hyperacute rejection: Accelerated rejection in a discordant model by adoptive transfer of specific cell subsets. Transplantation 1995:59:171.
14. INVERARDI L, SAMAJA M, MOTTERLINI R, et al. Early recognition of a discordant xenogeneic organ by human circulating lymphocytes. J Immunol 1992:149:1416.
15. ONO K, LINDSEY ES. Improved technique of heart transplantation in rats. J Thorac Cardiovasc Surg 1969:57:225.
16. KIPPS TJ, MEISENHOLDER G, ROBBINS BA. New developments in flow cytometric analyses of lymphocyte markers. Clin Lab Med 1992:12:237.
17. LEVENTHAL JR, JOHN R, FRYER JP, et al. Removal of baboon and human antiporcine IgG and IgM natural antibodies by immunoadsorption. Transplantation 1995:59:294-300.
18. ALEXANDRE GPJ, GIANELLO P, LATINNE D, et al. Plasmapharesis and splenectomy in experimental renal transplantation. In: Hardy MA ed. Xenograft 25. New York: Elsevier, 1989:67-68.
19. WHITE DJG, BRAIDLEY P, DUNNING J, et al. Hearts from pigs transgenic for human DAF are not hyperacutely rejected when xenografted to primates. Transpl Proc (in press).
20. BALDWIN WM, PRUITT SK, BRAUER RB, DAHA MR, SANFILIPPO F. Complement in organ transplantation. Transplantation 1995:59:797-808.
21. MILLAN MT, FERRAN C, STUHLMEIER KM, GECZY C, BACH FH. Human monocytes activate porcine aortic endothelial cells and may potentiate transplantation rejection in this species combination. Surg Forum 1995:46:392-395.
22. KAUL M, LOOS M. Collagen-like complement component C1q is a membrane protein of human monocyte-derived macrophages that mediates endocytosis. J Immunol 1995:155:5795-5802.
23. WORRAL NK, LAZENBY WD, MISKO TP, LIN TS, RODI CP, MANNING PT, TILTON RG, WILLIAMSON JR, FERGUSON TB. Modulation of in vivo alloreactivity by inhibition of inducible nitric oxide synthase. J Exp Med 1995: 181:63-70.
24. 6 in the rat is sufficient for complement-mediated hyperacute rejection of a guinea pig cardiac xenograft. Transplantation 1995:59:1073-1076.
25. YEDIDAG EN, LEVI E, BUCKINGHAM FC, et al. Early histopathology of small intestinal discordant xenografts. Transplantation 1996:62:1385.
26. 6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J Immunol 1993:151:7240-7248.
27. VAN ROOIJEN N. The liposome-mediated macrophage "suicide" technique. J Immunol Methods 1989:124:1-6.
28. HUITINGA I, DAMOISEAUX JG, VAN ROOIJEN N, et al. Liposome mediated affection of monocytes. Immunobiology 1992:185:11-19.
29. DUKSTRA CD, DOPP EA, JOLING P, et al. The heterogeneity of mononuclear phagocytes in lymphoid organs: Distinct macrophage subpopulations in the rat recognized by monoclonal antibodies ED1, ED2 and ED3. Immunology 1985:54:589.
30. SEEBACH JD, YAMADA K, DERSIMONIAN H, et al. Xenogeneic human anti-pig cytotoxicity mediated by activated natural killer cells. Xenotransplantation 1996:3:188.
31. GUTTMAN RD. In vitro correlates of rejection. I. Suppressive effect and specificity in mixed lymphocyte interaction of alloantiserum producing hyperacute rejection. Transpl Proc 1977:9:755.
32. BOLTON EM, GRACIE JA, BRIGGS JD, et al. Cellular requirements for renal allograft rejection in the athymic nude rat. J Exp Med 1989:169:1931.
33. OLUWOLE SF, ENGELSTAD K, HARDY MA. Cellular immunity in allograft rejection: role of lymphocyte subpopulations and T-cell subsets in rat cardiac allograft rejection. Cell Immunol 1989:124:24.